CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D)
Dec 1, 2024, 00:00
10.1016/j.jval.2024.10.165
https://www.valueinhealthjournal.com/article/S1098-3015(24)03028-6/fulltext
Title :
CO89 Reductions in Concomitant Medication Use and HbA1c Impact Following Initiation of an Advanced Hybrid Closed-Loop System (AHCL) Versus Multiple Daily Injection (MDI) Therapy in People With Type 2 Diabetes (T2D)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)03028-6&doi=10.1016/j.jval.2024.10.165
First page :
Section Title :
Open access? :
No
Section Order :
11074